MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-018-20055-3

Медицинская библиотека · Scientific reports · 2018

Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke.

Martí-Fàbregas Joan, Medrano-Martorell Santiago, Merino Elisa, Prats-Sánchez Luis, Marín Rebeca, Delgado-Mederos Raquel, Camps-Renom Pol, Martínez-Domeño Alejandro, Gómez-Choco Manuel, Lara Lidia, Casado-Naranjo Ignacio, Cánovas David, Torres Maria José, Freijo Marimar, Calleja Ana, Bravo Yolanda, Cocho Dolores, Rodríguez-Campello Ana, Zandio Beatriz, Fuentes Blanca, de Felipe Alicia, Llull Laura, Maestre José, Hernández María, Garcés Moisès, De Arce-Borda Ana Maria, Palomeras Ernest, Rodríguez-Yáñez Manuel, Díaz-Maroto Inma, Serrano Marta, Fernández-Domínguez Jéssica, Sanahuja Jordi, Purroy Francisco, Zedde Marialuisa, Delgado-Mengual Jordi, Gich Ignasi

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

We investigated whether pre-treatment with statins is associated with surrogate markers of amyloid and hypertensive angiopathies in patients who need to start long-term oral anticoagulation therapy. A prospective multicenter study of patients naive for oral anticoagulants, who had an acute cardioembolic stroke. MRI was performed at admission to evaluate microbleeds, leukoaraiosis and superficial siderosis. We collected data on the specific statin compound, the dose and the statin intensity. We performed bivariate analyses and a logistic regression to investigate variables associated with microbleeds. We studied 470 patients (age 77.5 ± 6.4 years, 43.7% were men), and 193 (41.1%) of them received prior treatment with a statin. Microbleeds were detected in 140 (29.8%), leukoaraiosis in 388 (82.5%) and superficial siderosis in 20 (4.3%) patients. The presence of microbleeds, leukoaraiosis or superficial siderosis was not related to pre-treatment with statins. Microbleeds were more frequent in patients with prior intracerebral hemorrhage (OR 9.7, 95% CI 1.06-90.9) and in those pre-treated antiplatelets (OR 1.66, 95% CI 1.09-2.53). Prior treatment with statins was not associated with markers of bleeding-prone cerebral angiopathies in patients with cardioembolic stroke. Therefore, previous statin treatment should not influence the decision to initiate or withhold oral anticoagulation if these neuroimaging markers are detected.

Для цитирования: Martí-Fàbregas Joan, Medrano-Martorell Santiago, Merino Elisa, Prats-Sánchez Luis, Marín Rebeca, Delgado-Mederos Raquel, Camps-Renom Pol, Martínez-Domeño Alejandro, Gómez-Choco Manuel, Lara Lidia, Casado-Naranjo Ignacio, Cánovas David, Torres Maria José, Freijo Marimar, Calleja Ana, Bravo Yolanda, Cocho Dolores, Rodríguez-Campello Ana, Zandio Beatriz, Fuentes Blanca, de Felipe Alicia, Llull Laura, Maestre José, Hernández María, Garcés Moisès, De Arce-Borda Ana Maria, Palomeras Ernest, Rodríguez-Yáñez Manuel, Díaz-Maroto Inma, Serrano Marta, Fernández-Domínguez Jéssica, Sanahuja Jordi, Purroy Francisco, Zedde Marialuisa, Delgado-Mengual Jordi, Gich Ignasi. Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke.. Scientific reports. 2018. DOI: 10.1038/s41598-018-20055-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.